Susquehanna International Group, LLP Amryt Pharma PLC Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$6.85 - $8.87 $423,035 - $547,784
-61,757 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$6.3 - $10.86 $98,613 - $169,991
-15,653 Reduced 20.22%
61,757 $510,000
Q4 2021

Feb 14, 2022
SELL
$9.44 - $12.24 $463,740 - $601,290
-49,125 Reduced 38.82%
77,410 $836,000
Q3 2021

Nov 15, 2021
BUY
$9.63 - $12.47 $1.22 Million - $1.58 Million
126,535 New
126,535 $1.53 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email